AstraZeneca PLC
11064.00
24-January-25 11:29:50
15 minutes delayed
Stocks
0.00
0.00%
Today's range
11024.00 - 11140.00
ISIN
N/A
Source
Cboe
-
Is Now the Right Time to Buy AstraZeneca Stock?
10 Dec 2023 07:46:15 By NASDAQ US Markets
-
Absci (ABSI) Up on AstraZeneca Deal to Design New Cancer Therapy
05 Dec 2023 09:27:21 By NASDAQ Stocks
-
Absci, AstraZeneca Join To Deliver AI-designed Antibody Against Oncology Target
04 Dec 2023 08:12:31 By NASDAQ US Markets
-
AstraZeneca To Discontine STABILIZE-CKD, DIALIZE-Outcomes Trials Under CRYSTALIZE Programme
01 Dec 2023 02:39:09 By NASDAQ US Markets
-
AstraZeneca Launches Evinova Healthtech Business
20 Nov 2023 09:21:15 By NASDAQ US Markets
-
Pharma Stock Roundup: FDA Okays AZN's Capivasertib & MRK's Keytruda Expanded Use
17 Nov 2023 09:20:24 By NASDAQ Stocks
-
AstraZeneca: Truqap Plus Faslodex Approved In US For HR+ Breast Cancer
17 Nov 2023 03:04:07 By NASDAQ US Markets
-
Interesting AZN Put And Call Options For July 2024
16 Nov 2023 11:57:01 By NASDAQ Stocks
-
AstraZeneca : Phase III Trial Of Imfinzi + Chemoradiotherapy In Lung Cancer Fails To Meet Main Goal
14 Nov 2023 03:55:47 By NASDAQ US Markets
-
AstraZeneca (AZN) Beats on Q3 Earnings & Sales, Ups 2023 View
10 Nov 2023 09:14:44 By NASDAQ Stocks
-
AstraZeneca Plc (AZN) Q3 2023 Earnings Call Transcript
09 Nov 2023 18:26:41 By NASDAQ US Markets
-
AstraZeneca Paying Up To $2 Billion For Experimental Obesity Pill—As Weight Loss Drug Market Grows
09 Nov 2023 09:57:51 By Forbes - World
-
09 Nov 2023 06:19:20 By MarketWatch
-
09 Nov 2023 05:10:57 By MarketWatch
-
AstraZeneca Reaches Obesity Drug Deal; Imfinzi Combination Meets Main Goal In Liver Cancer Trial
09 Nov 2023 03:55:26 By NASDAQ US Markets
-
AstraZeneca Q3 Pre-tax Profit Climbs; Lifts FY Outlook
09 Nov 2023 03:28:56 By NASDAQ US Markets
-
US FTC disputes listing for more than 100 patents in FDA Orange Book
07 Nov 2023 13:01:35 By NASDAQ US Markets
-
AstraZeneca (AZN) to Report Q3 Earnings: What's in the Cards?
06 Nov 2023 14:44:08 By NASDAQ Stocks
-
AstraZeneca : Canada Approves Ultomiris For Adults With Neuromyelitis Optica Spectrum Disorder
01 Nov 2023 07:46:39 By NASDAQ US Markets
-
Cellectis Announces Collaboration Agreement With AstraZeneca; To Receive Up To $245 Mln
01 Nov 2023 05:05:04 By NASDAQ US Markets